David_B._Robbins

David B. Robbins

David B. Robbins

American investor

David B. Robbins is an American lawyer, hedge fund manager, and private equity investor. He was formerly the chairman of Bally Technologies until its sale to Scientific Games in 2014 and currently serves as a managing partner in various investment partnerships, including Relativity Media, UltraV Holdings, Alexiam Capital, and Trevi Health Capital.

Quick Facts Nationality, Alma mater ...

Life and career

Robbins received his BS in Economics from the Wharton School of the University of Pennsylvania and his JD from the NYU School of Law.

Following a career as a corporate attorney, Robbins has founded and managed multiple private equity and growth capital funds, investing in media and entertainment, gaming, healthcare, and life sciences.

In 2005, Robbins co-founded Trevi Health Capital, a healthcare-focused private equity firm, with an emphasis on healthcare information and medical technology.[1]

He served as chairman of Bally Technologies (NYSE:BYI), a publicly traded gaming equipment and technology company from 1996 until its sale to Scientific Games (NASDAQ:SGMS) in 2014.[2][3]

In 2018, Robbins acquired Relativity Media, a film and television distribution and production company, through UltraV holdings,[4] a partnership between Robbins and SoundPoint Capital.[5][6][7][8]

Robbins has invested as a producer in multiple Broadway productions, most notably, Pippin, for which he received a Tony Award for Best Revival of a Musical in 2013.[9]

Civic engagement

Robbins’s family foundation focuses on medical research, with an emphasis in neurology, sponsoring research programs at the Columbia University Institute for Genomic Medicine[10] and NYU Langone Medical Center.

Robbins is an active supporter at NYU FACES[11] (Finding a Cure for Epilepsy and Seizures) and serves on the board of trustees for the McCarton Center[12] (addressing autism and developmental disabilities), the steering committee for the NYU Langone Comprehensive Epilepsy Center,[13] and Columbia University’s Precision Medicine Council.[14][15]

References

  1. [1]
    "Trevi Health Ventures". Cipherbio.com. Retrieved 2021-05-05.
  2. [2]
    Prior, Anna (August 1, 2014). "Scientific Games to Buy Bally Technologies". Wall Street Journal – via www.wsj.com.
  3. [3]
    "Bally recalls old guard with new chairman and CEO". Gaming Intelligence. May 16, 2014.
  4. [4]
    "UltraV Holdings - CB Insights". www.cbinsights.com.
  5. [5]
    "Welcome". Sound Point Capital. Retrieved 2021-05-05.
  6. [6]
    Khatchatourian, Maane (December 6, 2018). "Dealmakers Impact Report 2018".
  7. [7]
    Chmielewski, Dawn C. (August 16, 2018). "Bankruptcy Court OKs Sale Of Relativity Media To UltraV Holdings".
  8. [8]
    Maddaus, Gene (August 16, 2018). "Relativity Media Sale to UltraV Holdings Approved by Bankruptcy Judge".
  9. [9]
    Hetrick, Adam (March 23, 2013). "'Extraordinary!': High-Flying Circus-Inspired Pippin Revival Begins Previews March 23". Playbill.
  10. [10]
    "Institute for Genomic Medicine". Institute for Genomic Medicine. 2020-08-12. Retrieved 2021-05-05.
  11. [11]
    "In Memory of Jack Smith". FACES (Finding a Cure for Epilepsy and Seizures). 28 March 2022.
  12. [12]
    "McCarton". McCarton.
  13. [13]
    "Comprehensive Epilepsy Center". NYU Langone Health. 2021-05-05. Retrieved 2021-05-05.
  14. [14]
    "Precision Medicine". Precisionmedicine.columbia.edu. Retrieved 2021-05-05.
  15. [15]
    "Our Leadership". McCarton.
Share this article:

This article uses material from the Wikipedia article David_B._Robbins, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.